Can houseplants improve indoor air quality by removing CO2 and increasing relative humidity?

High indoor CO2 concentrations and low relative humidity (RH) create an array of well-documented human health issues. Therefore, assessing houseplants’ potential as a low-cost approach to CO2 removal and increasing RH is important. We investigated how environmental factors such as ’dry’ ( 0.30 m3 m-3) growing substrates, and indoor light levels (‘low’ 10 µmol m-2 s-1, ‘high’ 50 µmol m-2 s-1 and ‘very high’ 300 µmol m-2 s-1), influence the plants’ net CO2 assimilation (‘A’) and water-vapour loss. Seven common houseplant taxa – representing a variety of leaf types, metabolisms and sizes – were studied for their ability to assimilate CO2 across a range of indoor light levels. Additionally, to assess the plants’ potential contribution to RH increase, the plants’ evapo-transpiration (ET) was measured. At typical ‘low’ indoor light levels ‘A’ rates were generally low (< 3.9 mg hr-1). Differences between ‘dry’ and ’wet’ plants at typical indoor light levels were negligible in terms of room-level impact. Light compensation points (i.e. light levels at which plants have positive ‘A’) were in the typical indoor light range (1-50 µmol m-2 s-1) only for two studied Spathiphyllum wallisii cultivars and Hedera helix; these plants would thus provide the best CO2 removal indoors. Additionally, increasing indoor light levels to 300 µmol m-2 s-1 would, in most species, significantly increase their potential to assimilate CO2. Species which assimilated the most CO2 also contributed most to increasing RH

Field-testing solutions for drinking water quality monitoring in low- and middle-income regions and case studies from Latin American, African and Asian countries

Funding Information: This study is part of SAFEWATER Devices Translation and Implementation project supported by the Global Challenges Research Fund ( GCRF ) Global Research Translation Awards, UK Research and Innovation ( SAFEWATER Translate, EPSRC Grant Reference EP/T015470/1 ).Peer reviewedPublisher PD

Field-testing solutions for drinking water quality monitoring in low- and middle-income regions and case studies from Latin American, African and Asian countries

This study is part of SAFEWATER Devices Translation and Implementation project supported by the Global Challenges Research Fund (GCRF) Global Research Translation Awards, UK Research and Innovation (SAFEWATER Translate, EPSRC Grant Reference EP/T015470/1).This work highlights the need for a global approach to drinking water monitoring that involves facing several critical issues. Field tests that perform to very high standards of indicator microorganisms’ detection and confidence and, at the same time, being available in rural and isolated locations of low-income settings are urgently needed. Commercially available field-testing solutions for Escherichia coli determination based on hydrogen sulfide and defined substrate methods were critically reviewed, considering their capabilities and limitations, compliance against the UNICEF Target Product Profile (TPP), technology performance, availability, and cost. None of the available tests meets the standards set by the UNICEF TPP, the biggest limitation being the requirement of a power source. They need at least 18 to 24 h of incubation, hence they have not significantly decreased the amount of the time needed to complete an assay; and their applicability is generally limited by the sample volume. Additionally, there is still need for more accurate and standardised validation studiesthat open new opportunities for lowcost testing solutions in the field. On the other hand, traditional methods are the only ones legally authorised by national regulations in the case study locations, with a range of resources and technologies limitations. Despite the use of field kits is beginning to gain acceptance, its implementation in the field strongly relies on their availability and cost locally. Most field kits price exceed the maximum of 6 USD set by UNICEF, and they even cost significantly more when acquire from local distributors in developing countries

Effects of Irrigation Regimes and Rice Varieties on Methane Emissions and Yield of Dry Season Rice in Bangladesh

Adoption of the right rice variety and water-saving irrigation method could reduce greenhouse gas (GHG) emissions in lowland rice cultivation. A study was conducted at the research farm of Bangladesh Agricultural University, Mymensingh, Bangladesh, in 2019 during the Boro (dry) season to determine the impacts of different rice varieties (BRRI dhan29, BRRI dhan47, BRRI dhan69, Binadhan-8, Binadhan-10, and Binadhan-17) on methane (CH4) emissions under two irrigation methods, i.e., alternate wetting and drying (AWD) and continuous flooding (CF). The treatments were laid out in a split-plot design, considering water regime as the main plots and rice variety as the sub-plots. The emission rates of CH4 were determined by collecting air samples using the closed chamber technique and measuring the concentrations using a gas chromatograph. CH4 emission rates varied with the growth and development of the rice varieties. The lowest cumulative CH4 emission rate was observed in Binadhan-17, particularly under AWD irrigation. Across the rice varieties, AWD irrigation significantly reduced the cumulative CH4 emissions by about 35% compared with CF. No significant variation in rice yield was observed between AWD (5.38 t ha−1) and CF (5.16 t ha−1). This study suggests that the cultivation of Binadhan-17 under AWD irrigation could be effective at reducing the carbon footprint of lowland rice fields

Type and extent of trans-disciplinary co-operation to improve food security, health and household environment in low and middle income countries: systematic review

Acknowledgements: We are grateful to Dr Steve Turner and Dr Adam Price for their insightful comments that improved the manuscript. We would like to thank Heather Clark and Bimbola Kalejaiye for their help in data extraction. We are also grateful to Melanie Bickerton and Dr Amudha Poobalan for their systematic review advice.Peer reviewedPublisher PD

Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019

Background Disability and mortality burden of non-communicable diseases (NCDs) have risen worldwide; however, the NCD burden among adolescents remains poorly described in the EU.Methods Estimates were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Causes of NCDs were analysed at three different levels of the GBD 2019 hierarchy, for which mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) were extracted. Estimates, with the 95% uncertainty intervals (UI), were retrieved for EU Member States from 1990 to 2019, three age subgroups (10-14 years, 15-19 years, and 20-24 years), and by sex. Spearman's correlation was conducted between DALY rates for NCDs and the Socio-demographic Index (SDI) of each EU Member State.Findings In 2019, NCDs accounted for 86.4% (95% uncertainty interval 83.5-88.8) of all YLDs and 38.8% (37.4-39.8) of total deaths in adolescents aged 10-24 years. For NCDs in this age group, neoplasms were the leading causes of both mortality (4.01 [95% uncertainty interval 3.62-4.25] per 100 000 population) and YLLs (281.78 [254.25-298.92] per 100 000 population), whereas mental disorders were the leading cause for YLDs (2039.36 [1432.56-2773.47] per 100 000 population) and DALYs (2040.59 [1433.96-2774.62] per 100 000 population) in all EU Member States, and in all studied age groups. In 2019, among adolescents aged 10-24 years, males had a higher mortality rate per 100 000 population due to NCDs than females (11.66 [11.04-12.28] vs 7.89 [7.53-8.23]), whereas females presented a higher DALY rate per 100 000 population due to NCDs (8003.25 [5812.78-10 701.59] vs 6083.91 [4576.63-7857.92]). From 1990 to 2019, mortality rate due to NCDs in adolescents aged 10-24 years substantially decreased (-40.41% [-43.00 to -37.61), and also the YLL rate considerably decreased (-40.56% [-43.16 to -37.74]), except for mental disorders (which increased by 32.18% [1.67 to 66.49]), whereas the YLD rate increased slightly (1.44% [0.09 to 2.79]). Positive correlations were observed between DALY rates and SDIs for substance use disorders (r s=0.58, p=0.0012) and skin and subcutaneous diseases (r s=0.45, p=0.017), whereas negative correlations were found between DALY rates and SDIs for cardiovascular diseases (r s=-0.46, p=0.015), neoplasms (r s=-0.57, p=0.0015), and sense organ diseases (r s=-0.61, p=0.0005).Interpretation NCD-related mortality has substantially declined among adolescents in the EU between 1990 and 2019, but the rising trend of YLL attributed to mental disorders and their YLD burden are concerning. Differences by sex, age group, and across EU Member States highlight the importance of preventive interventions and scaling up adolescent-responsive health-care systems, which should prioritise specific needs by sex, age, and location. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license

Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019

Background: Disability and mortality burden of non-communicable diseases (NCDs) have risen worldwide; however, the NCD burden among adolescents remains poorly described in the EU. Methods: Estimates were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Causes of NCDs were analysed at three different levels of the GBD 2019 hierarchy, for which mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) were extracted. Estimates, with the 95% uncertainty intervals (UI), were retrieved for EU Member States from 1990 to 2019, three age subgroups (10–14 years, 15–19 years, and 20–24 years), and by sex. Spearman's correlation was conducted between DALY rates for NCDs and the Socio-demographic Index (SDI) of each EU Member State. Findings: In 2019, NCDs accounted for 86·4% (95% uncertainty interval 83·5–88·8) of all YLDs and 38·8% (37·4–39·8) of total deaths in adolescents aged 10–24 years. For NCDs in this age group, neoplasms were the leading causes of both mortality (4·01 [95% uncertainty interval 3·62–4·25] per 100 000 population) and YLLs (281·78 [254·25–298·92] per 100 000 population), whereas mental disorders were the leading cause for YLDs (2039·36 [1432·56–2773·47] per 100 000 population) and DALYs (2040·59 [1433·96–2774·62] per 100 000 population) in all EU Member States, and in all studied age groups. In 2019, among adolescents aged 10–24 years, males had a higher mortality rate per 100 000 population due to NCDs than females (11·66 [11·04–12·28] vs 7·89 [7·53–8·23]), whereas females presented a higher DALY rate per 100 000 population due to NCDs (8003·25 [5812·78–10 701·59] vs 6083·91 [4576·63–7857·92]). From 1990 to 2019, mortality rate due to NCDs in adolescents aged 10–24 years substantially decreased (–40·41% [–43·00 to –37·61), and also the YLL rate considerably decreased (–40·56% [–43·16 to –37·74]), except for mental disorders (which increased by 32·18% [1·67 to 66·49]), whereas the YLD rate increased slightly (1·44% [0·09 to 2·79]). Positive correlations were observed between DALY rates and SDIs for substance use disorders (rs=0·58, p=0·0012) and skin and subcutaneous diseases (rs=0·45, p=0·017), whereas negative correlations were found between DALY rates and SDIs for cardiovascular diseases (rs=–0·46, p=0·015), neoplasms (rs=–0·57, p=0·0015), and sense organ diseases (rs=–0·61, p=0·0005). Interpretation: NCD-related mortality has substantially declined among adolescents in the EU between 1990 and 2019, but the rising trend of YLL attributed to mental disorders and their YLD burden are concerning. Differences by sex, age group, and across EU Member States highlight the importance of preventive interventions and scaling up adolescent-responsive health-care systems, which should prioritise specific needs by sex, age, and location. Funding: Bill &amp; Melinda Gates Foundation

Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021

Background: Anaemia is a major health problem worldwide. Global estimates of anaemia burden are crucial for developing appropriate interventions to meet current international targets for disease mitigation. We describe the prevalence, years lived with disability, and trends of anaemia and its underlying causes in 204 countries and territories. Methods: We estimated population-level distributions of haemoglobin concentration by age and sex for each location from 1990 to 2021. We then calculated anaemia burden by severity and associated years lived with disability (YLDs). With data on prevalence of the causes of anaemia and associated cause-specific shifts in haemoglobin concentrations, we modelled the proportion of anaemia attributed to 37 underlying causes for all locations, years, and demographics in the Global Burden of Disease Study 2021. Findings: In 2021, the global prevalence of anaemia across all ages was 24·3% (95% uncertainty interval [UI] 23·9–24·7), corresponding to 1·92 billion (1·89–1·95) prevalent cases, compared with a prevalence of 28·2% (27·8–28·5) and 1·50 billion (1·48–1·52) prevalent cases in 1990. Large variations were observed in anaemia burden by age, sex, and geography, with children younger than 5 years, women, and countries in sub-Saharan Africa and south Asia being particularly affected. Anaemia caused 52·0 million (35·1–75·1) YLDs in 2021, and the YLD rate due to anaemia declined with increasing Socio-demographic Index. The most common causes of anaemia YLDs in 2021 were dietary iron deficiency (cause-specific anaemia YLD rate per 100 000 population: 422·4 [95% UI 286·1–612·9]), haemoglobinopathies and haemolytic anaemias (89·0 [58·2–123·7]), and other neglected tropical diseases (36·3 [24·4–52·8]), collectively accounting for 84·7% (84·1–85·2) of anaemia YLDs. Interpretation: Anaemia remains a substantial global health challenge, with persistent disparities according to age, sex, and geography. Estimates of cause-specific anaemia burden can be used to design locally relevant health interventions aimed at improving anaemia management and prevention. Funding: Bill &amp; Melinda Gates Foundation